Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Spain / NCT06794528
Recruiting Not applicable

Therapeutic Exercise Through Exergames on Mobile Devices for Cervical Rehabilitation

NCT06794528 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2025-01-16
Last updated
2025-01-28

Condition(s) studied

Neck Pain

Investigational drug(s) / intervention(s)

RehbeCa mobile applicationHome exercise program

RehbeCa mobile application: The system consists of a mobile application (to be used by patients) and a web application (to be used by physiotherapists) that allows monitoring of the patient's performance without the need for attendance, thus facilitating telerehabilitation. The mobile application consists of a serious game that aims to induce the patient to perform neck exercises, adapting to their capacity and evolution at all times through artificial intelligence. The patient's interaction with the mobile application is based on the integration of a vision-based head-tracker to track the movements of the patient's head. The web application aims to provide professionals with a tool to monitor the evolution of their patients through the data captured by the mobile application.

Home exercise program: Set of therapeutic exercises to be carried out at home. They are taught face-to-face, and also printed on a leaflet that is delivered to the participant.

Study summary

The objective of this study is to determine whether performing cervical therapeutic exercises using a serious game through a mobile application enhances treatment adherence compared to performing the same exercises at home following standard practice.

Eligibility

Sex
ALL
Min age
18 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: * Persons of legal age with cervicalgia. * Have a smart mobile device (smartphone or tablet) on which to download the App. Exclusion Criteria: * Acute musculoskeletal pathological processes or exacerbation (less than 15 days of evolution). Includes presentation of symptoms such as paraesthesia, radiating pain, loss of strength in the upper limb. * Episodes of severe pain more than 15 days of evolution. * Accident with cervical or dorsal injury within the last month. * Refusing to sign the informed consent. * Not having a device suitable for installation or lack of experience in the use of smart mobile devices. * Baseline NDI score of less than 5. * Presence of red flags: * Suspicion of fracture: advanced age, previous trauma, osteoporosis. * Suspicion of neurological involvement: loss of sensation in extremities, loss of strength or muscle mass. * Suspicion of infection: fever, night sweats. * Suspicion of cancer: Previous history of cancer, no improvement in one month of treatment, weight loss, headache, vomiting. * Suspicion of systemic disease: headache, fever, malaise, general headache, fever, malaise, unilateral skin rash (herpes).

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University of the Balearic Islands Palma de Mallorca Balearic Islands Recruiting

More Universitat de les Illes Balears trials in Spain

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06794528 on ClinicalTrials.gov ↗ ← All trials in Spain